Nandana Das

4, Raja S, C, Mullick Road, 700 032
Kolkata, WB, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia.

PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia.

Journal: JCO clinical cancer informatics

Published: January 21, 2026

Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022).

Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022).

Journal: The Lancet regional health. Southeast Asia

Published: January 17, 2026

Biogeneric Native and Polyethylene Glycol-conjugated Escherichia coli Asparaginases for Treating Children with Acute Lymphoblastic Leukemia.

Biogeneric Native and Polyethylene Glycol-conjugated Escherichia coli Asparaginases for Treating Children with Acute Lymphoblastic Leukemia.

Journal: Therapeutic drug monitoring

Published: December 08, 2025

Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India.

Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India.

Journal: The Lancet regional health. Southeast Asia

Published: January 25, 2025

Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.

Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.

Journal: Cancer medicine

Published: January 20, 2022

Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India.

Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India.

Journal: Trials

Published: May 24, 2021

Substantial Evidences Indicate That Inorganic Arsenic Is a Genotoxic Carcinogen: a Review.

Substantial Evidences Indicate That Inorganic Arsenic Is a Genotoxic Carcinogen: a Review.

Journal: Toxicological research

Published: August 12, 2018

Association of single nucleotide polymorphism with arsenic-induced skin lesions and genetic damage in exposed population of West Bengal, India.

Association of single nucleotide polymorphism with arsenic-induced skin lesions and genetic damage in exposed population of West Bengal, India.

Journal: Mutation research. Genetic toxicology and environmental mutagenesis

Published: June 15, 2016

Association of NALP2 polymorphism with arsenic induced skin lesions and other health effects.

Association of NALP2 polymorphism with arsenic induced skin lesions and other health effects.

Journal: Mutation research

Published: December 31, 2012

Arsenic-induced toxicity and carcinogenicity: a two-wave cross-sectional study in arsenicosis individuals in West Bengal, India.

Arsenic-induced toxicity and carcinogenicity: a two-wave cross-sectional study in arsenicosis individuals in West Bengal, India.

Journal: Journal of exposure science & environmental epidemiology

Published: September 20, 2012

Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India.

Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India.

Journal: BMC public health

Published: April 02, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026